Primary Packaging Plastics - Ophthalmic/nasal applications

Our moulded glass product lines cover all the pharmaceutically relevant glass categories using borosilicate glass of type I and soda-silica glass of types II and III. In addition to our products made of amber and clear glass, we also produce coloured pharma glass and opaque opal glass. Our product ...

We offer a widely varied spectrum of packaging solutions within solid, liquid and ophthalmic applications. Our leading brands are Duma®, Dudek™ and Triveni for solid dosage, edp-branded PET bottles for liquid dosage. Our standard range includes a wide choice of different types of containers and closure...

Sensile Medical is a pioneer in liquid drug delivery pump devices with a typical total volume of 3 – 20 ml. The subcutaneous medication at home combined with digital solutions is attractive for all stakeholders of the health care System.

Customized drug delivery systems – from the concept development through industrialization to assembly, and pharmaceutical filling. We cover the entire spectrum of delivery types: inhaler, syringes, pen systems, auto injectors and infusion sets as well as lab disposables and point of care tests.

Primary packaging for sensitive, biotechnologically manufactured active agents. Highest quality standards with regard to active agent-packaging interaction, increased user-friendliness and application safety for patients and user.

Our Duma, Dudek and Triveni branded products include a broad range of containers in HDPE and caps in LDPE & PP for the pharmaceutical market. A wide choice of solid dosage, closure and security systems makes the range fully adaptable to the individual requirements of the customer. Our assortment in...

We offer a comprehensive range of edp-branded PET bottles for liquids and closures in HDPE and PP for different applications. All our bottles can be supplied with caps, reducers and other accessories. Some are optionally available with a measuring cup that has a 2.5 to 10 ml scale or a measuring cup wi...

Our monolayer plastic vials unite the best properties of plastic and glass packaging for liquid medications. The vials are available with a single-layer structure based on Cyclic Olefin Polymer (COP). The vials offer inert contact surface and have been proven with various pharma applications in the market....

Since 2015 Centor is a member of the Gerresheimer Group and the largest supplier of regulatory compliant prescription plastic containers for medication dispensing for the North American prescription retail market. The product portfolio includes the flagship products 1-Clic® vials and closure systems,...

Gx® RTF vials enhance flexibility by facilitating packaging needs from clinical stage to industrialization with the common goal to minimize customer product risks and optimize total cost of ownership. Gerresheimer combines the competencies in converting glass tubes to serum/ injection vials and tra...

The Gx Elite vials are the result of a careful product development process spanning several years. The highly shatter-resistant vials are extremely durable and free of cosmetic defects. They also boast an incredibly robust structure, while their resistance to delamination protects the drug inside. Simp...

Our tubular vials product range includes clear and amber vials in glass types I, II and III from 0.6 to 100 ml. We produce different designs, with or without blowback, according to industry standards or to individual specifications. As a special feature we offer sterile RTF® vials based on its long e...

Dietmar Siemssen, CEO of German primary packaging manufacturer Gerresheimer, states that approximately 4% of the company’s revenue growth each year to come from deals with drugmakers of weight loss and diabetes products, particularly GLP-1 class drugs. 

Gerresheimer Primary Packaging Plastics specializesin the widely varied spectrum of pharmaceuticalplastic packaging within solid, liquid andophthalmic applications, plastic vials and plasticbottles for personal care.

Holger Krenz will be speaking at CPHI Milan about Gerresheimer’s platform solutions for primary packaging and drug delivery systems. His presentation will focus on the product benefits of the Gx Elite performance level which are the ideal packaging components for reliable functionality of drug delivery systems.

Ensure highest product quality and lowest cosmetic defects Accelerate drug development by most comprehensive data packages Create tailored system options with state-of-the-art technologies and components Offer best fit for demanding drug formulations by addressing bio-pharmaceutical requirements

"As a solution provider with a unique & dedicated product portfolio​, Gerresheimer is continuously exploring options to better accommodate their customers along the drug development and drug LCM journey. With its newly installed product platforms, Gerresheimer will be combining outstanding quality levels with specific product requirements in dedicated application fields and disease areas. From dental care over hematology, vaccines, diabetes and metabolism disorders into complex and more demanding areas such as Cell Gene Therapy, ophthalmology and oncology ... Gerresheimer will be able to support even better in finding the best containment solution for their specific application. Picking one example, we'll elaborate on our offering in the ophthalmology field ..."

How can device and packaging innovation influence patient ability and motivation to use their treatment?" With examples from research of how patients learn and become motivated, and how industry can use these processes to influence patient outcomes. Patients learn through a mixture of stimuli and learning processes, these stimuli can be adopted into device design and packaging to enhance the patient's feelings about their medication. Presently many patients using complex devices, like inhalers, make critical errors which entails repeated re-training. This presentation looks at innovative ways of embedding learning, that could be adopted by future device and packaging design.

What are blister packs, and why are they so important? How have they changed over the years, and where are they heading? This presentation will consider a history of how blister packs have benefitted the supply of medicines to patients worldwide, and how they are continuing to evolve within an increasingly sustainable landscape.

Wearables can take different shapes and sizes and are revolutionizing the way we monitor, treat, and manage health conditions. In this short deep dive, we will look at innovative wearable technologies and how they enable data collection and analysis, patient centric care, personalized medicine and more.

Overcoming challenges when developing subcutaneous drug delivery devices that empower patient self-administration. The trend in parenteral patient therapy has been moving towards the home-care setting for some time as it empowers patient independence. However, home administration brings additional requirements when developing a delivery device, and these are constantly evolving. Patient safety is always paramount, but usability is another critical factor, as well as sustainability and connectivity to support patient adherence. The challenge is to design a device to meet as many requirements as possible that can be ready on the market within 4-8 years. In this presentation we will discuss Gerresheimer’s mission of “innovating for a better life” and how we apply this when developing solutions that respond to the needs of patients, our pharmaceutical industry customers, and the environment, today and into the future.

The talk explores the current integration of digital health in drug delivery and various opportunities that it presents. Delving into the landscape of drug delivery, we examine the rise of connected devices, emphasizing the delicate balance between technology and compassionate care. This session also addresses real-world challenges like adoption, satisfaction, regulatory, and security considerations. Be part of the conversation on overcoming these challenges.

From sight, touch, taste, and smell to hearing, the five senses allow the body to take everything in. Research shows that the more senses are used, the better the memory is gathered, and the process enhanced. How does this theory apply to device development, design conception, and patient experience?